Brief: Diamyd Medical - Positive Safety Evaluation Of Remygen®

Diamyd Medical AB

14/01/2021 11:40

Jan 14 (Reuters) - Diamyd Medical AB  DMYDb.ST :
    * POSITIVE SAFETY EVALUATION OF REMYGEN® IN HIGH DOSE AND IN COMBINATION WITH ALPRAZOLAM
GIVES THE
GO-AHEAD FOR THE CONTINUATION OF THE TRIAL

Source text for Eikon:  ID:nWkr7MjmHr 
Further company coverage:  DMYDb.ST 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))